Want to see AU:BMT full AI Analyst Report?
Top Page
Beamtree Holdings Ltd
(Sydney:BMT)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.08
▼(-32.50% Downside)
Action:Reiterated
Date:10/09/26
The score is held back mainly by persistent losses (including a large 2026 net loss) and balance-sheet equity erosion, despite strong revenue growth and low leverage. Technicals are also weak with price below all key moving averages and negative MACD. Recent positive free cash flow is supportive but not yet consistent enough to materially lift the overall profile.
Positive Factors
Strong revenue growth
Revenue growth of more than three times over five years indicates expanding demand and improving commercial scale. If sustained, this larger revenue base can support broader customer adoption, operating leverage, and increased capacity to fund product development and healthcare-sector expansion.
Negative Factors
Persistent unprofitability
Persistent operating and net losses show that strong revenue growth has not yet translated into a sustainable earnings model. The particularly large 2026 loss and negative gross profit raise concerns about cost structure and the ability to scale profitably over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Revenue growth of more than three times over five years indicates expanding demand and improving commercial scale. If sustained, this larger revenue base can support broader customer adoption, operating leverage, and increased capacity to fund product development and healthcare-sector expansion.
Read all positive factors
Beamtree Holdings Ltd (BMT) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$24.51M
Dividend YieldN/A
Average Volume (3M)117.97K
Price to Earnings (P/E)―
Beta (1Y)1.06
Revenue Growth2.08%
EPS Growth-195.31%
CountryAU
Employees93
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.06
Shares Outstanding295,342,600
10 Day Avg. Volume36,932
30 Day Avg. Volume117,971
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.74
Price to Sales (P/S)1.39
P/FCF Ratio52.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.25Price Target Upside108.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$29.00M
Beamtree Holdings Ltd Business Overview & Revenue Model
Company Description
Headquartered in Redfern, Australia, Beamtree Holdings Limited, founded in 1996, develops and markets cutting-edge clinical decision support (CDS) solutions for the healthcare sector, both within Australia and globally. The company offers a divers...
How the Company Makes Money
Beamtree makes money primarily by licensing and providing access to its healthcare software and data products to customers such as hospitals and other healthcare organisations. Revenue is typically generated through recurring software fees (e.g., ...
Beamtree Holdings Ltd Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
62
Positive
Cash Flow
54
Neutral
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 29.19M | 28.60M | 27.60M | 22.77M | 16.55M |
| Gross Profit | -738.00K | 28.60M | 4.89M | 2.14M | -202.00K |
| EBITDA | -4.99M | -808.00K | -331.00K | -1.26M | -2.28M |
| Net Income | -18.27M | -6.16M | -5.11M | -6.91M | -4.45M |
Balance Sheet | |||||
| Total Assets | 37.38M | 54.29M | 59.65M | 62.53M | 63.91M |
| Cash, Cash Equivalents and Short-Term Investments | 2.51M | 4.78M | 5.04M | 8.81M | 6.35M |
| Total Debt | 4.04M | 3.26M | 1.66M | 755.00K | 1.12M |
| Total Liabilities | 14.03M | 12.36M | 12.52M | 15.31M | 15.33M |
| Stockholders Equity | 23.35M | 41.93M | 47.14M | 47.22M | 48.58M |
Cash Flow | |||||
| Free Cash Flow | 780.00K | -1.84M | -4.51M | -1.88M | -4.83M |
| Operating Cash Flow | 931.00K | 609.00K | -492.00K | 768.00K | -2.32M |
| Investing Cash Flow | -3.89M | -2.45M | -4.02M | -2.65M | -5.16M |
| Financing Cash Flow | 694.00K | 1.58M | 749.00K | 4.34M | -286.00K |
Beamtree Holdings Ltd Technical Analysis
Negative
0.12
Price Trends
0.11
Negative
0.12
Negative
0.14
Negative
Market Momentum
>-0.01
Positive
32.44
Neutral
-0.06
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:BMT, the sentiment is Negative. The current price of 0.12 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.11, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 32.44 is Neutral, neither overbought nor oversold. The STOCH value of -0.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:BMT.
Beamtree Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$17.31B | 65.25 | 63.19% | 0.42% | 22.87% | 130.30% | |
61 Neutral | AU$133.63M | 58.24 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$117.49M | -6.82 | -203.69% | ― | -1.53% | 28.29% | |
47 Neutral | AU$50.53M | -5.66 | -24.29% | ― | -17.35% | -47.29% | |
47 Neutral | AU$19.88M | -2.19 | -1688.04% | ― | 11.45% | 0.69% | |
46 Neutral | AU$24.51M | -1.32 | -58.13% | ― | 2.08% | -195.31% |
* Healthcare Sector Average
AU:BMT
Beamtree Holdings Ltd
0.08
-0.12
-58.50%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.14
-0.06
-30.00%
AU:PME
Pro Medicus Limited
165.73
-121.19
-42.24%
AU:M7T
Mach7 Technologies
0.22
-0.08
-27.12%
AU:ALC
Alcidion Group Limited
0.10
<0.01
10.00%
AU:PCK
PainChek Ltd
0.10
-0.55
-85.16%
Beamtree Holdings Ltd Corporate Events
Beamtree Cancels Over 6.1 Million Unvested Performance Rights
Oct 6, 2026
Beamtree Holdings Ltd has notified the market that 6,178,334 performance rights, classified as BMTAC securities, have ceased. The lapse occurred because the conditions attached to these performance rights were not met or became incapable of being ...
Beamtree Director Martin Bowles Increases Indirect Shareholding
Aug 31, 2026
Beamtree Holdings Limited has disclosed a change in director Martin Bowles’ indirect interest in the company’s securities, following an on-market purchase by Bowles Group Investments Pty Ltd, an entity of which he is a director. The tr...
Beamtree issues new shares with cleansing notice to support compliant trading
Aug 28, 2026
Beamtree Holdings Limited has issued 2,478,667 fully paid ordinary shares without a prospectus under the Corporations Act, relying on cleansing notice provisions to enable secondary trading of the new stock. The company confirmed it is up to date ...
Beamtree Lodges 2026 Corporate Governance Statement with ASX
Aug 27, 2026
Beamtree Holdings Limited operates in the corporate governance and compliance domain as an ASX-listed entity. The company focuses on adhering to ASX Corporate Governance Council principles and recommendations, and discloses its governance framewor...
Beamtree sharpens focus on core AI health platforms as recurring revenue rises
Aug 27, 2026
Beamtree has completed a strategic review that refines its product mix, streamlines costs and sharpens sales execution, while appointing former TechnologyOne executive Gareth Pye as chief executive to accelerate commercialisation. The company is c...
Beamtree Reports Lapse of 3 Million Performance Rights
Aug 14, 2026
Beamtree Holdings Ltd has notified the market of the lapse of 3,000,000 performance rights, recorded under the ASX security code BMTAC. These rights ceased on 24 July 2026 because the vesting or performance conditions attached to them were not met...
Beamtree issues 1 million new shares under cleansing notice
Aug 10, 2026
Beamtree Holdings Ltd has issued 1,000,000 fully paid ordinary shares on 7 August 2026, notifying the market via a cleansing notice under section 708A of the Corporations Act. The shares were issued without a prospectus, in reliance on statutory d...
Beamtree Seeks ASX Quotation for 1 Million New Incentive Shares
Aug 10, 2026
Beamtree Holdings Ltd has applied to the ASX for quotation of 1,000,000 new ordinary fully paid shares, to be issued on 7 August 2026 under an employee incentive scheme. The move modestly increases the company’s quoted share capital and unde...
Beamtree issues over 1.1m new shares under cleansing notice
Aug 3, 2026
Beamtree Holdings has issued 1,167,761 fully paid ordinary shares, notifying the market via a cleansing notice under section 708A of the Corporations Act. The company confirmed the shares were issued without a prospectus, stated it is compliant wi...
Beamtree Seeks ASX Quotation for 1.17 Million New Shares
Aug 3, 2026
Beamtree Holdings Ltd has applied for quotation on the ASX of 1,167,761 new ordinary fully paid shares under the ticker BMT, with an issue date of 3 August 2026. The new securities, issued as part of previously announced transactions, will expand ...
Beamtree Plans Share Placement of Over 1.1 Million New Shares
Jul 31, 2026
Beamtree Holdings Ltd has notified the ASX of a proposed issuance of 1,167,761 ordinary fully paid shares. The new securities will be issued via a placement or similar capital raising mechanism, with the proposed issue date set for 3 August 2026.T...
Beamtree Lifts Equity Sign-On Grant for New CEO Gareth Pye
Jul 31, 2026
Beamtree Holdings Limited has revised the sign-on equity package for newly appointed Chief Executive Officer Gareth Pye, increasing the one-off grant of fully paid ordinary shares from $100,000 to $150,000 in value. The adjustment is intended to b...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.